top of page
This site was designed with the
.com
website builder. Create your website today.Start Now

Research

Google Scholar page
 
Peer-reviewed publications​ - as an author

 

  1. Grand TS, Basarir H, Jackson LJ. The cost-effectiveness of oral contraceptives compared to ‘no hormonal treatment’ for endometriosis-related pain: An economic evaluation. PLOS ONE. (link)

  2. Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H, White D (2018). Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open, 8(4): e016766. (link)

  3. Rowen DL, Labeit A, Stevens K, Elliot J, Mulhern B, Carlton J, Basarir H, Brazier J (2018). Estimating a preference-based single index measuring the quality of life impact of self-management for diabetes. Medical Decision Making, 38 (6); 699-707. (link)

  4. Carlton J, Elliott J, Rowen D, Stevens K, Basarir H, Meadows K, Brazier J. Developing a questionnaire to determine the impact of self-management in diabetes: giving people with diabetes a voice. Health and Quality of Life Outcomes, 15(1): 146. (link)

  5. Rowen D, Stevens K, Labeit A, Elliott J, Mulhern B, Carlton J, Basarir H, Ratcliffe J, Brazier J (2017). Using a discrete choice experiment involving cost to value a classification system measuring the quality of life impact of self-management for diabetes, Value in Health, 21 (1), 69-77. (link)

  6. Basarir H, Brennan A, Jacques R, Pollard D, Stevens K, Freeman J, Wales J, Price K. Cost-effectiveness of structured education in children with type-1 diabetes mellitus. International Journal of Technology Assessment in Health Care, 32 (4), 203-211. (link)

  7. Hykin P, Sivaprasad S, Prevost AT, Vasconcelos J, Murphy C, Kelly J, Brazier JE, Basarir H et al. LEAVO: A Multicentre Phase III Double-masked Randomised Controlled Non-Inferiority Trial comparing the clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema (MO) due to Central Retinal Vein Occlusion (CRVO). Lancet. (link)

  8. Karimi M, Brazier JE, Basarir H. The Capability Approach: A Critical Review of Its Application in Health Economics. Value in Health. (link)

  9. Tappenden P, Ren S, Archer R, Martyn-St James M, Harvey R, Basarir H Stevens J, Cantrell A, Lobo A, Hoque, S. A model-based economic evaluation of biologic and non-biologic options for the treatment of adults with moderately-to-severely active ulcerative colitis after the failure of conventional therapy. Pharmacoeconomics; 34 (10), 1023–1038. (link)

  10. Peasgood, T., Brennan, A., Mansell, P., Elliott, J., Basarir, H., & Kruger, J. (2016). The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with Type I diabetes. Medical Decision Making. (link)

  11. Archer R, Tappenden P, Ren S, James MS, Harvey R, Basarir H, Stevens J, Carroll C, Cantrell A, Lobo A, Hoque S (2016). Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technology Assessment, 20(39):1-326. (link)

  12. Marsh K. Möller J, Basarir H, Orfanos P, Detzel P. (2016). The Economic Impact of Lower Protein Infant Formula for the Children of Overweight and Obese Mothers. Nutrients, 8(1), 18. (link)

  13. Kruger J, Pollard DJ , Basarir H , Thokala P , Cooke D, Clark M, Bond R, Heller S, Brennan A (2015). Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models: A Case Study in Type 1 Diabetes. Medical Decision Making, 35 (7), 872-887. (link)

  14. Gomersall T, Spencer S, Basarir H, Tsuchiya A, Clegg J (2015). Measuring quality of life in children with speech and language difficulties: A systematic review of existing approaches. International Journal of Language & Communication Disorders; 50 (4), 416–435, (link)

  15. Dalley C, Basarir H, Wright JG, Fernando M, Pearson D, Ward SE, Thokala P, Krishnankutty A, Wilson G, Dalton A, Talley P, Barnett D, Hughes D, Porter NR, Reilly JT, Snowden JA (2015). Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model. Journal of Clinical Pathology; 68 (4), 292-300 (link)

  16. Heller S, Lawton J, Amiel S, Cooke D, Mansell P, Brennan A, Elliott J, Boote J, Emery C, Baird W, Basarir H et al. Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes. Programme Grants for Applied Rresearch; Vol 2(5), Dec 2014 (link).

  17. Ara R, Basarir H, Keetharuth AD, Barbieri M, Weatherly HL, Sculpher MJ, Ahmed H & Brown S. (2014). Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review. International journal of technology assessment in health care; 30(4), 381-393. (link)

  18. Barbieri M, Weatherly HL, Ara R, Basarir H, Sculpher M, Adams R, Ahmed H, Coles C, Guerrero-Urbano T, Nutting C, Powell M. (2014) What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer. Appl Health Econ Health Policy; 12(5): 497-510 (link)

  19. Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J, Heller S. (2014). Assessing the cost‐effectiveness of Type 1 diabetes interventions: the Sheffield Type 1 Diabetes Policy Model. Diabetic Medicine, 31(4), 477-486. (link)

  20. Kruger J, Brennan A, Thokala P, Basarir H, Jacques R, Elliott J, Heller S, Speight J. (2013). The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model. Diabetic Medicine; 30(10): 1236–1244. (link)

  21. Ara R, Basarir H, Ward SE. (2012). Principles of health economic evaluations of lipid-lowering strategies. Curr Opin Lipidol.; 23(4): 271-81. (link)

  22. Basarir H. (2011). Poor, multidimensionally speaking: Evidence from South Africa. Journal of African Economies; 20(3): 463-504. (link)

​

Peer-reviewed publications​ - as member of a research group
​

  1. REPOSE Study Group. (2017). Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ, 356, j1285. (link)

  2. Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, Amiel S, Barnard K, Beckwith A, Brennan A, Campbell M et al. and REPOSE Study Group (2017). A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Health Technology Assessment; 21(20):1-278. (link)

  3. Price KJ, Knowles JA, Fox M, Wales JK, Heller S, Eiser C, Freeman JV and for the KICk–OFF Study group. (2016) Effectiveness of the Kids in Control of Food (KICk–OFF) structured education course for 11–16 year olds with Type 1 diabetes. Diabetic Medicine. 33(2):192-203. (link)

  4. Lawton J, Kirkham J, Rankin D, White DA, Elliott J, Jaap A, Smithson WH, Heller S and on behalf of the REPOSE Group. (2016) Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial. Diabetic Medicine. 33(2):243-51. (link)

  5. Elliott J, Rankin D, Jacques RM, Lawton J, Emery CJ, Campbell MJ, Dixon S, Heller SR and on behalf of the NIHR DAFNE Research Study Group. (2015) A cluster randomized controlled non-inferiority trial of 5-day Dose Adjustment for Normal Eating (DAFNE) training delivered over 1 week versus 5-day DAFNE training delivered over 5 weeks: the DAFNE 5x1-day trial. Diabetic Medicine. 32(3):391-8. (link)

  6. Lawton J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, Heller S, Elliott J, REPOSE Group (2014). Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: a longitudinal qualitative investigation. Diabetes Research and Clinical Practice. 31; 106(3): 443-50. (link)

  7. White D, Waugh N, Elliott J, Lawton J, Barnard K, Campbell MJ, Dixon S, Heller S and on behalf of the REPOSE Group. (2014) The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial. BMJ open. 4(9). (link)

 

Reports​

 

  1. Archer R, Tappenden P, Ren S, Martyn-St James M, Harvey R, Basarir H, Stevens J, Carroll C, Carntrell A, Lobo A, Hoque S (2014). Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262) [ID695]. Technology Assessment Report commissioned by the NIHR HTA Programme on behalf of the National Institute for Health and Care Excellence. (link)

  2. Revill P, Lahiff E, Ryan P, Outram V, Thomas S, Basarir H. (2009). HIV/AIDS programs in Africa and the global economics crisis - an assessment of the particular vulnerability of treatment programs to interruptions in funding: a case study of Malawi. Economics Reference Group - Sixth Meeting (December 2009). (link)
 
 

Conferences/Talks

 

  1. Basarir H, Brennan A, Jacques R, Pollard DJ, Stevens K, Freeman J, Wales J, Price K. The cost-effectiveness of the Kids in Control OF Food (KICk-OFF) structured education programme in a paediatric population with type 1 diabetes mellitus in the UK. British Society for Paediatric Endocrinology and Diabetes. November, 2015.

  2. Marsh K, Moller J, Basarir H, Orfanos P, Detzel P. The economic impact of lower-protein infant formula for the children of overweight and obese mothers. ISPOR Europe, Milan, Italy. November, 2015.

  3. Basarir H, Brennan A, Jacques R, Pollard DJ, Stevens K, Freeman J, Wales J, Price K (2013). The cost-effectiveness of the Kids in Control OF Food (KICk-OFF) structured education programme in a paediatric population with type 1 diabetes mellitus in the UK. International Society for Pediatric and Adolescent Diabetes (ISPAD) and Australasian Paediatric Endocrine Group (APEG) Joint Conference, Brisbane, Australia. October, 2015.

  4. Basarir H, Pollard D, Brennan A, Elliot J, Heller S and Campbell M.  The potential value of ongoing support in Type-1 diabetes mellitus with DAFNEplus: Exploratory Pre-Trial Cost-effectiveness analysis on proposed trial endpoint target for 12 month HbA1c improvement. ISPOR 17th Annual European Congress, Amsterdam, Netherlands 2014
  5. Basarir H, Ara R, Brazier JE, Sculpher M, Manca A, Bojke L, Preston L.Shared Decision Making Conceptual Framework for Economic Evaluations. Advisory Group Meeting, Economic Evaluation of Health and Social Care Interventions Policy Research Unit, Sheffield, UK, 2014.
  6. Basarir H, Ara R, et al. Are policy decisions on surgical procedures in cancer informed by robust economic evidence? A systematic review of economic evidence of surgical interventions for breast, colorectal or prostate cancer. ISPOR 16th Annual European Congress, Dublin, Ireland 2013
  7. Basarir H et al. The cost-effectiveness of structured education delivery over 5 weeks versus 5 days for Type-1 Diabetes Mellitus using the Sheffield Type-1 Diabetes Policy Model, HTAi, Seoul, Korea 2013
  8. Basarir H.  Is it all relative? The role of wealth on the migration decision: Evidence from Indonesia. "Migration: Economic Change, Social Challenge" Conference, London, 2011
  9. Basarir H.  Is it all relative? The role of wealth on the migration decision: Evidence from Indonesia. 6th PhD Presentation Meeting of the Royal Economic Society, London, UK, 2011
  10. Basarir H. The effect of relative wealth on subjective health: Evidence from Indonesia. Centre for Historical Economics and Related Research at York, York, UK, 2011
  11. Basarir H. Poor, multidimensionally speaking: Evidence from South Africa” Ten Years of ‘War against Poverty’ Conference,Manchester, UK, 2010
  12. Basarir H. Poor, multidimensionally speaking: Evidence from South Africa” IARIW 31st General Conference, St. Gallen, Switzerland, 2010
  13. Basarir H.  Is it all relative? The role of wealth on the migration decision: Evidence from Indonesia. Applied Microeconometrics Cluster Workshop, York, UK, 2010
  14. Basarir H. Poor, multidimensionally speaking: Evidence from South Africa” Equal Opportunities International Conference, Istanbul, Turkey, 200
  15. Basarir H. Poor, multidimensionally speaking: Evidence from South Africa” Nordic Conference in Development Economics, Oscarsborg, Norway, 2009
  16. Basarir H. Poor, multidimensionally speaking: Evidence from South Africa” PhD Research Workshop, York, UK, 2009
 
 
bottom of page